Amgen

Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field
Endpoints
Thu, 09/29/16 - 08:23 am
Novartis
Amgen
CGRP blockers
migraines
erenumab
Amgen and Arrowhead to develop gene-therapies for heart disease
Yahoo/Reuters
Thu, 09/29/16 - 08:18 am
Amgen
Arrowhead
R&D
gene therapy
heart disease
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thu, 09/29/16 - 08:14 am
FDA
AbbVie
Amgen
biosimilars
Humira
Amjevita
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thu, 09/29/16 - 08:13 am
Amgen
Kyprolis
clinical trials
Multiple Myeloma
Amgen's Osteoporosis Drug Crosses a Hurdle
Investopedia
Tue, 09/27/16 - 10:14 pm
Amgen
osteoporosis
romosozumab
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
How Much Will Consumers Save on New Humira Biosimilar?
24/7 Wall St
Mon, 09/26/16 - 09:48 am
Humira
biosimilars
Amjevita
AbbVie
Amgen
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Fri, 09/23/16 - 10:24 pm
FDA
Amgen
Humira
rheumatoid arthritis
AbbVie
biosimilars
The drug industry might finally have an answer for migraines
Stat
Fri, 09/23/16 - 09:52 am
migraines
Amgen
Eli Lilly
Alder Biopharma
Teva Pharmaceutical
CGRP blockers
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Tue, 09/20/16 - 09:51 am
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Amgen Products Threatened by Court Losses
Investopedia
Mon, 09/19/16 - 03:45 pm
Amgen
Apobiologix
Neupogen
Grastofil
Neulasta
Lapelga
biosimilars
patents
Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug
Endpoints
Mon, 09/19/16 - 09:53 am
Amgen
romosozumab
Radius Health
abaloparatide
osteoporosis
Amgen's Biosimilar Approval And Astra's Anti-PD-L1 Data
Seeking Alpha
Sun, 09/18/16 - 09:54 am
Amgen
biosimilars
AstraZeneca
anti-PD-L1
ABP 501
Humira
durvalumab
Gilead Sciences, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Motley Fool
Mon, 09/12/16 - 09:34 am
Gilead Sciences
M&A
JNJ
Novartis
Amgen
Pfizer
Merck
Amgen Has Many Ways to Win
TheStreet.com
Tue, 09/6/16 - 09:56 am
Amgen
Amgen, Inc: How Damaging Will Be Novartis’ Enbrel Copy
Bidness, ETC
Wed, 08/31/16 - 10:46 am
Amgen
Enbrel
Novartis
biosimilars
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Yahoo/AP
Wed, 08/31/16 - 09:27 am
Novartis
biosimilars
Amgen
Enbrel
rheumatoid arthritis
Erelzi
Amgen, Sanofi and Regeneron trot out new PCSK9 data at European heart meeting
Fierce Pharma
Mon, 08/29/16 - 05:52 pm
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Repatha
Praluent
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year
Motley Fool
Sun, 08/28/16 - 10:07 am
PCSK9 inhibitors
Amgen
Repatha
Regeneron
Praluent
Sanofi
That big new hyperparathyroidism drug from Amgen? The FDA rejected it
Endpoints
Thu, 08/25/16 - 09:38 am
secondary hyperparathyroidism
Amgen
FDA
AMG416

Pages